Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1995 Feb;58(2):167–173. doi: 10.1136/jnnp.58.2.167

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

S J Collins 1, J E Ahlskog 1, J E Parisi 1, D M Maraganore 1
PMCID: PMC1073312  PMID: 7876846

Abstract

All cases examined postmortem at the Mayo Clinic that met the classic neuropathological criteria for progressive supranuclear palsy (PSP) were identified for retrospective clinical analyses. The necropsy material was re-examined by a second neuropathologist to confirm the pathological diagnosis of PSP, yielding 12 cases. A range of clinical signs were documented in these patients, with numerous findings beyond those noted in the original descriptions of this disorder. Atypical clinical findings included absence of supranuclear gaze palsy (two cases), prominent asymmetry (two), arm dystonia (two), upper limb apraxia (two), myoclonus (two), chorea (one), eyelid opening apraxia (one), and respiratory disturbance (one). A definite clinical diagnosis of PSP had been made during life in only eight of the 12 patients. From the retrospective analysis of these 12 cases, a set of clinical criteria were developed for the premortem diagnosis of PSP emphasising differences from other akinetic-rigid disorders.

Full text

PDF
167

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brusa A., Mancardi G. L., Bugiani O. Progressive supranuclear palsy 1979: an overview. Ital J Neurol Sci. 1980 Oct;1(4):205–222. doi: 10.1007/BF02336701. [DOI] [PubMed] [Google Scholar]
  2. Calabrese V. P., Hadfield M. G. Parkinsonism and extraocular motor abnormalities with unusual neuropathological findings. Mov Disord. 1991;6(3):257–260. doi: 10.1002/mds.870060311. [DOI] [PubMed] [Google Scholar]
  3. Chamberlain W. Restriction in upward gaze with advancing age. Trans Am Ophthalmol Soc. 1970;68:234–244. [PMC free article] [PubMed] [Google Scholar]
  4. D'Antona R., Baron J. C., Samson Y., Serdaru M., Viader F., Agid Y., Cambier J. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain. 1985 Sep;108(Pt 3):785–799. doi: 10.1093/brain/108.3.785. [DOI] [PubMed] [Google Scholar]
  5. David N. J., Mackey E. A., Smith J. L. Further observations in progressive supranuclear palsy. Neurology. 1968 Apr;18(4):349–356. doi: 10.1212/wnl.18.4.349. [DOI] [PubMed] [Google Scholar]
  6. Davis P. H., Bergeron C., McLachlan D. R. Atypical presentation of progressive supranuclear palsy. Ann Neurol. 1985 Apr;17(4):337–343. doi: 10.1002/ana.410170406. [DOI] [PubMed] [Google Scholar]
  7. Fearnley J. M., Lees A. J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991 Oct;114(Pt 5):2283–2301. doi: 10.1093/brain/114.5.2283. [DOI] [PubMed] [Google Scholar]
  8. Fearnley J. M., Revesz T., Brooks D. J., Frackowiak R. S., Lees A. J. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry. 1991 Feb;54(2):159–161. doi: 10.1136/jnnp.54.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gibb W. R., Luthert P. J., Marsden C. D. Corticobasal degeneration. Brain. 1989 Oct;112(Pt 5):1171–1192. doi: 10.1093/brain/112.5.1171. [DOI] [PubMed] [Google Scholar]
  10. Golbe L. I., Davis P. H., Schoenberg B. S., Duvoisin R. C. Prevalence and natural history of progressive supranuclear palsy. Neurology. 1988 Jul;38(7):1031–1034. doi: 10.1212/wnl.38.7.1031. [DOI] [PubMed] [Google Scholar]
  11. Jellinger K., Riederer P., Tomonaga M. Progressive supranuclear palsy: clinico-pathological and biochemical studies. J Neural Transm Suppl. 1980;(16):111–128. doi: 10.1007/978-3-7091-8582-7_12. [DOI] [PubMed] [Google Scholar]
  12. Karson C. N., Burns R. S., LeWitt P. A., Foster N. L., Newman R. P. Blink rates and disorders of movement. Neurology. 1984 May;34(5):677–678. doi: 10.1212/wnl.34.5.677. [DOI] [PubMed] [Google Scholar]
  13. Klawans H. L., Jr, Ringel S. P. Observations on the efficacy of L-dopa in progressive supranuclear palsy. Eur Neurol. 1971;5(2):115–129. doi: 10.1159/000114065. [DOI] [PubMed] [Google Scholar]
  14. Kosaka K., Matsushita M., Oyanagi S., Uchiyama S., Iwase S. Pallido-nigro-luysial atrophy with massive appearance of corpora amylacea in the CNS. Acta Neuropathol. 1981;53(2):169–172. doi: 10.1007/BF00689999. [DOI] [PubMed] [Google Scholar]
  15. Leenders K. L., Frackowiak R. S., Lees A. J. Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography. Brain. 1988 Jun;111(Pt 3):615–630. doi: 10.1093/brain/111.3.615. [DOI] [PubMed] [Google Scholar]
  16. Maher E. R., Lees A. J. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1986 Jul;36(7):1005–1008. doi: 10.1212/wnl.36.7.1005. [DOI] [PubMed] [Google Scholar]
  17. Pfaffenbach D. D., Layton D. D., Jr, Kearns T. P. Ocular manifestations in progressive supranuclear palsy. Am J Ophthalmol. 1972 Dec;74(6):1179–1184. doi: 10.1016/0002-9394(72)90740-4. [DOI] [PubMed] [Google Scholar]
  18. Quinn N. Multiple system atrophy--the nature of the beast. J Neurol Neurosurg Psychiatry. 1989 Jun;Suppl:78–89. doi: 10.1136/jnnp.52.suppl.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rafal R. D., Friedman J. H. Limb dystonia in progressive supranuclear palsy. Neurology. 1987 Sep;37(9):1546–1549. doi: 10.1212/wnl.37.9.1546. [DOI] [PubMed] [Google Scholar]
  20. Rebeiz J. J., Kolodny E. H., Richardson E. P., Jr Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 1968 Jan;18(1):20–33. doi: 10.1001/archneur.1968.00470310034003. [DOI] [PubMed] [Google Scholar]
  21. Riley D. E., Lang A. E., Lewis A., Resch L., Ashby P., Hornykiewicz O., Black S. Cortical-basal ganglionic degeneration. Neurology. 1990 Aug;40(8):1203–1212. doi: 10.1212/wnl.40.8.1203. [DOI] [PubMed] [Google Scholar]
  22. STEELE J. C., RICHARDSON J. C., OLSZEWSKI J. PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. Arch Neurol. 1964 Apr;10:333–359. doi: 10.1001/archneur.1964.00460160003001. [DOI] [PubMed] [Google Scholar]
  23. Sandroni P., Ahlskog J. E., Fealey R. D., Low P. A. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res. 1991 Jun;1(2):147–155. doi: 10.1007/BF01826212. [DOI] [PubMed] [Google Scholar]
  24. Steele J. C. Progressive supranuclear palsy. Brain. 1972;95(4):693–704. [PubMed] [Google Scholar]
  25. Stern M. B., Braffman B. H., Skolnick B. E., Hurtig H. I., Grossman R. I. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology. 1989 Nov;39(11):1524–1526. doi: 10.1212/wnl.39.11.1524. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES